Protalix Biotherapeutics, Inc. (PLX)
2.21
-0.58
(-20.79%)
USD |
NYAM |
Mar 18, 16:00
2.21
0.00 (0.00%)
After-Hours: 05:48
Protalix Biotherapeutics Market Cap : 177.73M for March 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Denali Therapeutics, Inc. | 3.181B |
| Lisata Therapeutics, Inc. | 45.25M |
| OraSure Technologies, Inc. | 200.47M |
| Nephros, Inc. | 32.46M |
| Agenus, Inc. | 135.89M |
Market Cap Related Metrics
| PS Ratio | 3.343 |
| Price to Book Value | 3.685 |
| Price | 2.21 |
| Earnings Yield | -3.82% |